Over the past week, the United States market has risen by 2.2%, contributing to an 8.2% increase over the last year, with earnings projected to grow by 14% annually in the coming years. In this environment of steady growth, identifying stocks that are estimated to be below their intrinsic value can offer investors potential opportunities for long-term gains. Top 10 Undervalued Stocks Based On Cash Flows In The United States Name Current Price Fair Value (Est) Discount (Est) FB Financial (NYSE:FBK) $44.62 $89.12 49.9% MINISO Group Holding (NYSE:MNSO) $18.53 $36.62 49.4% MetroCity Bankshares (NasdaqGS:MCBS) $28.33 $55.11 48.6% Owens Corning (NYSE:OC) $144.46 $284.31 49.2% German American Bancorp (NasdaqGS:GABC) $38.57 $74.67 48.3% Pure Storage (NYSE:PSTG) $47.58 $93.52 49.1% Ready Capital (NYSE:RC) $4.44 $8.67 48.8% HealthEquity (NasdaqGS:HQY) $91.42 $179.14 49% Live Oak Bancshares (NYSE:LOB) $26.93 $52.48 48.7% Coeur Mining (NYSE:CDE) $5.45 $10.87 49.8% Click here to see the full list of 176 stocks from our Undervalued US Stocks Based On Cash Flows screener. Let's explore several standout options from the results in the screener. AppLovin Overview: AppLovin Corporation develops a software-based platform aimed at improving marketing and monetization for advertisers both in the United States and globally, with a market cap of approximately $104.07 billion. Operations: AppLovin's revenue is derived from two main segments: Apps, generating $1.49 billion, and Advertising, contributing $3.22 billion. Estimated Discount To Fair Value: 11.4% AppLovin is trading at US$301.84, below its estimated fair value of US$340.64, indicating potential undervaluation based on cash flows. Despite impressive earnings growth of 344.3% over the past year and a forecasted annual profit growth rate of 22.5%, concerns arise from legal challenges alleging fraudulent advertising practices and high debt levels. The recent appointment of Maynard Webb to the board may strengthen governance amidst these issues, while M&A rumors involving TikTok suggest strategic expansion possibilities. Upon reviewing our latest growth report, AppLovin's projected financial performance appears quite optimistic. Click to explore a detailed breakdown of our findings in AppLovin's balance sheet health report.NasdaqGS:APP Discounted Cash Flow as at May 2025 Bilibili Overview: Bilibili Inc. offers online entertainment services targeting young audiences in China and has a market cap of $7.58 billion. Operations: The company's revenue primarily comes from its Internet Information Providers segment, totaling CN¥26.83 billion. Estimated Discount To Fair Value: 40.6% Story Continues Bilibili, trading at US$18.28, is significantly undervalued compared to its fair value estimate of US$30.79. The company is expected to become profitable within three years, with revenue growth projected at 9.2% annually—outpacing the broader U.S. market's 8.4%. Recent results highlight a reduced net loss for 2024 and a completed share buyback worth $16.36 million, reflecting strategic financial management amidst ongoing revenue expansion efforts for 2025. Insights from our recent growth report point to a promising forecast for Bilibili's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Bilibili.NasdaqGS:BILI Discounted Cash Flow as at May 2025 Sotera Health Overview: Sotera Health Company offers sterilization, lab testing, and advisory services for the healthcare industry across the United States, Canada, Europe, and internationally, with a market cap of $3.51 billion. Operations: The company generates revenue through its Nordion segment at $181.91 million, Nelson Labs at $223.84 million, and Sterigenics at $701.04 million. Estimated Discount To Fair Value: 43.9% Sotera Health, trading at US$12.92, is significantly undervalued with an estimated fair value of US$23.03. Despite recent earnings challenges and a net loss in Q1 2025, the company maintains a robust growth forecast with earnings expected to rise significantly over the next three years. However, interest payments remain a concern due to insufficient coverage by current earnings. Revenue growth projections are modest at 5.6% annually, trailing behind broader market expectations. Our earnings growth report unveils the potential for significant increases in Sotera Health's future results. Click here to discover the nuances of Sotera Health with our detailed financial health report.NasdaqGS:SHC Discounted Cash Flow as at May 2025 Seize The Opportunity Click here to access our complete index of 176 Undervalued US Stocks Based On Cash Flows. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Curious About Other Options? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:APPNasdaqGS:BILI and NasdaqGS:SHC. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
May 2025's Noteworthy Stocks Estimated Below Intrinsic Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...